genetic diseases, inborn
Showing 1 - 25 of 32
Healthy Volunteer, Muscular Dystrophies, Muscular Disorders, Atrophic Trial in Madison (EDG-5506 Tablet, Radiolabeled EDG-5506
Recruiting
- Healthy Volunteer
- +7 more
- EDG-5506 Tablet
- +2 more
-
Madison, WisconsinLabcorp Clinical Research Unit, Inc.
Feb 7, 2023
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)
Recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Nashville, Tennessee
- +5 more
Feb 2, 2023
Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic Trial in Little Rock, Sacramento, Atlanta
Recruiting
- Muscular Dystrophies
- +7 more
- CAP-1002
- Placebo
-
Little Rock, Arkansas
- +9 more
Jan 9, 2023
Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)
Recruiting
- Prader-Willi Syndrome
- +20 more
- Guanfacine Extended Release
- Placebo
-
Brooklyn, New YorkMaimonides Medical Center
Dec 20, 2022
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
DM1, Muscular Dystrophies, Myotonic Dystrophy Trial in United States (Placebo, AOC 1001)
Enrolling by invitation
- DM1
- +12 more
- Placebo
- AOC 1001
-
Los Angeles, California
- +7 more
Jul 27, 2022
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic Trial in Worldwide (Ataluren, PLACEBO)
Active, not recruiting
- Muscular Dystrophy, Duchenne
- +8 more
- Ataluren
- PLACEBO
-
Phoenix, Arizona
- +71 more
Mar 30, 2022
Evaluating Prenatal Exome Sequencing Study
Enrolling by invitation
- Congenital Anomalies
- +2 more
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Centre
Mar 21, 2022
Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
Recruiting
- Muscular Dystrophies
- +3 more
-
Washington, District of ColumbiaChildren's National Health System
Mar 1, 2022
Data of Current FVIII Prophylaxis Replacement Therapy in Adult
Active, not recruiting
- Blood Coagulation Disorder
- +8 more
- Standard of Care FVIII Replacement therapy
-
San Francisco, California
- +10 more
Feb 18, 2022
Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, Inherited Trial in United States
Recruiting
- Adeno-Associated Virus (AAV)
- +16 more
- SPK-8016
-
Los Angeles, California
- +13 more
Feb 3, 2022
Dermatitis, Atopic, Dermatitis, Eczema Trial in Hamilton (Benralizumab, Placebo Control)
Completed
- Dermatitis, Atopic
- +9 more
- Benralizumab
- Placebo Control
-
Hamilton, Ontario, CanadaMcMaster Cardio-Respiratory Research Lab
Oct 14, 2021
Human Growth Hormone Treatment in Small for Gestational Age
Not yet recruiting
- Small for Gestational Age Infant
- +2 more
- Blood collection for genetic analysis
- (no location specified)
Sep 27, 2021
Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Placebo)
Completed
- Dermatitis
- +9 more
- PF-04965842 100 mg
- +2 more
-
Birmingham, Alabama
- +234 more
Sep 17, 2021
Utilizing Free DNA in Embryo Culture for PGT
Completed
- Chromosome Abnormalities
- +2 more
- NGS reading for Media Free DNA
- (no location specified)
Aug 13, 2021
Children With Metachromatic Leukodystrophy
Terminated
- Lipid Metabolism Disorders
- +13 more
-
Torrance, California
- +13 more
Mar 16, 2021
Whole Genome Sequencing in the Neonatal Intensive Care Unit
Completed
- Genetic Diseases, Inborn
- Sequence
-
Hershey, PennsylvaniaPenn State Health Milton S. Hershey Medical Center
Jan 29, 2021
Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Dupilumab)
Completed
- Dermatitis
- +9 more
- PF-04965842 100 mg
- +4 more
-
Birmingham, Alabama
- +215 more
Dec 21, 2020
Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic Trial in Worldwide (Ataluren)
Terminated
- Muscular Dystrophy, Duchenne
- +8 more
-
Los Angeles, California
- +57 more
Aug 10, 2020
Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic Trial in Worldwide (Ataluren, Placebo)
Completed
- Muscular Dystrophy, Duchenne
- +8 more
- Ataluren
- Placebo
-
Los Angeles, California
- +54 more
Jul 17, 2020
Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic Trial in United States (CAP-1002, Placebo)
Completed
- Muscular Dystrophies
- +7 more
- CAP-1002
- Placebo
-
Sacramento, California
- +6 more
Jun 3, 2020
Neurodevelopment Dysplasia of Fetal Brain Caused by ASNS Gene
Unknown status
- Asparagine Synthetase Deficiency
- Genetic Diseases, Inborn
-
Chang Chun, Jilin, ChinaBo Chen
Jul 3, 2018
Symptomatic Domains Most Relevant to Charcot Marie Tooth
Completed
- Charcot Marie Tooth Disease (CMT)
- +6 more
-
Tampa, FloridaRDCRN Data Management and Coordinating Center , Epidemiology Cen
Jun 9, 2017